secwatch / observer
8-K filed February 23, 2023, 6:59 PM ET ticker DH CIK 0001861795
earnings confidence high sentiment neutral materiality 0.75

Definitive Healthcare Q4 revenue up 31% to $60.6M; FY23 guidance implies 14% growth

Definitive Healthcare Corp.

2022-FY EPS reported -$0.06 revenue$222,653,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Definitive Healthcare Corp. reported fourth quarter ended December 31, 2022 results: revenue $60.6 million, net income $6.7 million. Guidance initiated.

Period
fourth quarter ended December 31, 2022
Revenue
$60.6 million
Net income
$6.7 million
Guidance
initiated
Result
reported results
Exact text from the filing
Fourth Quarter 2022 Financial Highlights: • Revenue was $60.6 million, an increase of 31% from $46.3 million in Q4 2021. • GAAP Net Income (loss) was $6.7 million, or 11% of revenue, compared to $(14.8) million, or 32% of revenue in Q4 2021.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Definitive Healthcare Corp. reported full year ended December 31, 2022 results: revenue $222.7 million, net income $(22.3) million. Guidance initiated.

Period
full year ended December 31, 2022
Revenue
$222.7 million
Net income
$(22.3) million
Guidance
initiated
Result
reported results
Exact text from the filing
Full Year 2022 Financial Highlights: • Revenue was $222.7 million for the year, an increase of 34% from $166.2 million for the full year 2021. • GAAP Net loss was $(22.3) million, or 10% of revenue, compared to $(61.3) million, or 37% of revenue for the full year 2021.
View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

Definitive Healthcare Corp. filing history →

Source: SEC EDGAR
accession 0000950170-23-004128
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.